Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	SOX6 NCOA2 CUX2 SALL3 ETV1 NSD1 JDP2 RFX6 FOXA2 RXRA RXRG HIVEP3 SOX7 TP63 ZNF335 PITX1 NR5A2 HES4 MAFB DLX5 EP300 DNMT3A	5.08e-06	1244	121	22	GO:0000978
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	SOX6 NCOA2 CUX2 SALL3 ETV1 NSD1 JDP2 RFX6 FOXA2 RXRA RXRG HIVEP3 SOX7 TP63 ZNF335 PITX1 NR5A2 HES4 MAFB DLX5 EP300 DNMT3A	7.15e-06	1271	121	22	GO:0000987
GeneOntologyMolecularFunction	chromatin binding	NCOA2 BCAS3 KAT6A NSD1 JDP2 FOXA2 RXRA HP1BP3 SF3B1 SUPT6H TP63 NR5A2 SMARCA2 AUTS2 EP300 DNMT3A	1.01e-05	739	121	16	GO:0003682
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	SOX6 NCOA2 CUX2 SALL3 ETV1 NSD1 JDP2 RFX6 FOXA2 RXRA RXRG HIVEP3 SOX7 TP63 ZNF335 PITX1 NR5A2 HES4 MAFB DLX5 EP300 DNMT3A	5.95e-05	1459	121	22	GO:0000977
GeneOntologyMolecularFunction	A2A adenosine receptor binding	NECAB2 GRM5	1.09e-04	3	121	2	GO:0031687
GeneOntologyMolecularFunction	ErbB-2 class receptor binding	NRG1 MUC4	2.17e-04	4	121	2	GO:0005176
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC3A MUC4	2.17e-04	4	121	2	GO:0030197
GeneOntologyMolecularFunction	transcription coactivator activity	NCOA2 TCF20 KAT6A ZMIZ1 BCL9 MRTFB SMARCA2 EP300	5.24e-04	303	121	8	GO:0003713
GeneOntologyMolecularFunction	DNA binding domain binding	RXRA ATXN2	5.38e-04	6	121	2	GO:0050692
GeneOntologyMolecularFunction	transcription coregulator activity	NCOA2 NRG1 TCF20 KAT6A NSD1 ZMIZ1 BCL9 MRTFB SMARCA2 EP300 DNMT3A	6.23e-04	562	121	11	GO:0003712
GeneOntologyMolecularFunction	retinoic acid-responsive element binding	RXRA RXRG	7.50e-04	7	121	2	GO:0044323
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	SOX6 CUX2 SALL3 ETV1 JDP2 RFX6 FOXA2 RXRA RXRG HIVEP3 SOX7 TP63 PITX1 NR5A2 HES4 PLAGL2 MAFB DLX5 ZBTB3	8.30e-04	1412	121	19	GO:0000981
GeneOntologyMolecularFunction	adenosine receptor binding	NECAB2 GRM5	9.96e-04	8	121	2	GO:0031685
GeneOntologyMolecularFunction	nuclear thyroid hormone receptor binding	NCOA2 NSD1 RXRA	1.13e-03	34	121	3	GO:0046966
GeneOntologyMolecularFunction	molecular adaptor activity	UBL7 NCOA2 NRG1 TCF20 KAT6A NSD1 ZMIZ1 RB1CC1 BCL9 RXRG MRTFB MYH14 ANAPC1 ITSN2 SMARCA2 RIMS2 EP300 DNMT3A	1.34e-03	1356	121	18	GO:0060090
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	SOX6 NCOA2 TCF20 BCAS3 ETV1 RFX6 POGZ ZMIZ1 BCL9 FOXA2 RXRA RXRG SOX7 MRTFB SF3B1 SUPT6H TP63 ZNF335 PITX1 NR5A2 SMARCA2 AUTS2 PLAGL2 MAFB DLX5 EP300 CAVIN2	2.63e-08	1390	121	27	GO:0045944
GeneOntologyBiologicalProcess	embryo development	SOX6 KAT6A NSD1 ZMIZ1 STIL FOXA2 INO80D RXRA SOX7 SEC24D MRTFB SF3B1 SUPT6H TP63 KIAA1217 ZNF335 PITX1 NR5A2 NFRKB MAFB DLX5 GNAS EP300	9.10e-06	1437	121	23	GO:0009790
GeneOntologyBiologicalProcess	chromatin organization	KAT6A NSD1 JDP2 FOXA2 INO80D HP1BP3 M1AP SF3B1 SUPT6H TP63 ZNF335 SETBP1 NFRKB SMARCA2 GNAS EP300 DNMT3A	1.90e-05	896	121	17	GO:0006325
GeneOntologyBiologicalProcess	protein-DNA complex organization	KAT6A NSD1 JDP2 POGZ FOXA2 INO80D HP1BP3 M1AP SF3B1 SUPT6H TP63 ZNF335 SETBP1 NFRKB SMARCA2 GNAS EP300 DNMT3A	2.10e-05	999	121	18	GO:0071824
GeneOntologyBiologicalProcess	chromatin remodeling	KAT6A NSD1 JDP2 INO80D HP1BP3 SF3B1 SUPT6H TP63 ZNF335 SETBP1 NFRKB SMARCA2 GNAS EP300 DNMT3A	2.93e-05	741	121	15	GO:0006338
GeneOntologyBiologicalProcess	muscle organ development	SOX6 NRG1 ETV1 BCL9 RXRA HIVEP3 MRTFB MYH14 PITX1 EP300 MYBPC3	5.27e-05	436	121	11	GO:0007517
GeneOntologyBiologicalProcess	regulation of postsynaptic cytosolic calcium ion concentration	SYNPO GRM5 GRID2IP	5.40e-05	13	121	3	GO:0099566
GeneOntologyBiologicalProcess	head development	SOX6 NRG1 SALL3 KAT6A ZMIZ1 STIL FOXA2 MRTFB ATXN2 ZNF335 PITX1 NAV2 MAFB DLX5 EP300 MYO16	9.43e-05	919	121	16	GO:0060322
GeneOntologyCellularComponent	chromatin	SOX6 NCOA2 CUX2 BCAS3 KAT6A ETV1 NSD1 JDP2 RFX6 POGZ ZMIZ1 FOXA2 INO80D RXRA RXRG HP1BP3 SOX7 SF3B1 CSNK2A1 TP63 PITX1 NR5A2 NFRKB SMARCA2 HES4 MAFB DLX5 EP300 DNMT3A	3.50e-09	1480	120	29	GO:0000785
GeneOntologyCellularComponent	nuclear protein-containing complex	NCOA2 NSD1 JDP2 BCL9 SLA INO80D RXRA RXRG NUP35 SF3B1 ANAPC1 SUPT6H CSNK2A1 ZNF335 NR5A2 NFRKB SMARCA2 MAFB SRRM2	3.14e-04	1377	120	19	GO:0140513
Domain	Nuc_recep-AF1	RXRA RXRG	4.03e-05	2	119	2	PF11825
Domain	Nuc_recep-AF1	RXRA RXRG	4.03e-05	2	119	2	IPR021780
Domain	WWE	DTX4 DTX2	2.40e-04	4	119	2	SM00678
Domain	WWE-dom_subgr	DTX4 DTX2	2.40e-04	4	119	2	IPR018123
Domain	Nuc_rcpt_coact	NCOA2 EP300	5.94e-04	6	119	2	IPR009110
Domain	Na_channel_asu	SCN4A SCN9A	1.75e-03	10	119	2	IPR001696
Domain	Na_trans_assoc	SCN4A SCN9A	1.75e-03	10	119	2	IPR010526
Domain	Na_trans_assoc	SCN4A SCN9A	1.75e-03	10	119	2	PF06512
Domain	Retinoid-X_rcpt/HNF4	RXRA RXRG	1.75e-03	10	119	2	IPR000003
Domain	IQ	MYH14 SCN4A SCN9A MYO16	1.79e-03	81	119	4	SM00015
Domain	Znf_FYVE_PHD	TCF20 KAT6A NSD1 RIMS2 DNMT3A	2.51e-03	147	119	5	IPR011011
Domain	WWE	DTX4 DTX2	2.55e-03	12	119	2	PF02825
Domain	WWE-dom	DTX4 DTX2	2.55e-03	12	119	2	IPR004170
Domain	WWE	DTX4 DTX2	2.55e-03	12	119	2	PS50918
Domain	IQ_motif_EF-hand-BS	MYH14 SCN4A SCN9A MYO16	2.63e-03	90	119	4	IPR000048
Domain	IQ	MYH14 SCN4A SCN9A MYO16	2.96e-03	93	119	4	PS50096
Domain	H15	KAT6A HP1BP3	3.00e-03	13	119	2	SM00526
Domain	-	SYN3 RIMKLA	3.00e-03	13	119	2	3.40.50.20
Domain	H15	KAT6A HP1BP3	3.00e-03	13	119	2	PS51504
Domain	Znf_hrmn_rcpt	RXRA RXRG NR5A2	3.14e-03	46	119	3	IPR001628
Domain	NUCLEAR_REC_DBD_2	RXRA RXRG NR5A2	3.14e-03	46	119	3	PS51030
Domain	NUCLEAR_REC_DBD_1	RXRA RXRG NR5A2	3.14e-03	46	119	3	PS00031
Domain	ZnF_C4	RXRA RXRG NR5A2	3.14e-03	46	119	3	SM00399
Domain	zf-C4	RXRA RXRG NR5A2	3.14e-03	46	119	3	PF00105
Domain	Nuclear_hrmn_rcpt	RXRA RXRG NR5A2	3.14e-03	46	119	3	IPR001723
Domain	-	RXRA RXRG NR5A2	3.33e-03	47	119	3	1.10.565.10
Domain	Histone_H1/H5_H15	KAT6A HP1BP3	3.48e-03	14	119	2	IPR005818
Domain	SEA	MUC16 MUC3A	3.48e-03	14	119	2	SM00200
Domain	PreATP-grasp_dom	SYN3 RIMKLA	3.48e-03	14	119	2	IPR016185
Domain	Nucl_hrmn_rcpt_lig-bd	RXRA RXRG NR5A2	3.54e-03	48	119	3	IPR000536
Domain	HOLI	RXRA RXRG NR5A2	3.54e-03	48	119	3	SM00430
Domain	Hormone_recep	RXRA RXRG NR5A2	3.54e-03	48	119	3	PF00104
Domain	FH2	GRID2IP FMN2	4.00e-03	15	119	2	PS51444
Domain	FH2_Formin	GRID2IP FMN2	4.00e-03	15	119	2	IPR015425
Domain	FH2	GRID2IP FMN2	4.00e-03	15	119	2	PF02181
Domain	-	SYN3 RIMKLA	4.00e-03	15	119	2	3.30.1490.20
Domain	FH2	GRID2IP FMN2	4.00e-03	15	119	2	SM00498
Domain	VWF_type-D	VWDE MUC4	4.56e-03	16	119	2	IPR001846
Domain	VWFD	VWDE MUC4	4.56e-03	16	119	2	PS51233
Domain	VWD	VWDE MUC4	4.56e-03	16	119	2	SM00216
Domain	VWD	VWDE MUC4	4.56e-03	16	119	2	PF00094
Domain	-	RXRA RXRG NR5A2	5.75e-03	57	119	3	3.30.50.10
Domain	Channel_four-helix_dom	CACNA1E SCN4A SCN9A	5.75e-03	57	119	3	IPR027359
Domain	-	CACNA1E SCN4A SCN9A	5.75e-03	57	119	3	1.20.120.350
Domain	ATP_grasp_subdomain_1	SYN3 RIMKLA	5.76e-03	18	119	2	IPR013815
Domain	-	SYN3 RIMKLA	5.76e-03	18	119	2	3.30.470.20
Domain	Znf_NHR/GATA	RXRA RXRG NR5A2	6.03e-03	58	119	3	IPR013088
Domain	Ion_trans_dom	TRPM6 CACNA1E SCN4A SCN9A	6.10e-03	114	119	4	IPR005821
Domain	Ion_trans	TRPM6 CACNA1E SCN4A SCN9A	6.10e-03	114	119	4	PF00520
Pathway	REACTOME_SIGNALING_BY_NOTCH1	MAMLD1 DTX4 DTX2 EP300	4.25e-06	18	89	4	MM14775
Pathway	REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT	MAMLD1 RFX6 FOXA2 NR5A2 EP300	6.34e-06	42	89	5	M17541
Pathway	PID_AR_TF_PATHWAY	NCOA2 RXRA RXRG SMARCA2 EP300	2.02e-05	53	89	5	M151
Pathway	PID_RETINOIC_ACID_PATHWAY	NCOA2 RXRA RXRG EP300	3.59e-05	30	89	4	M207
Pathway	WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA	KAT6A NSD1 DTX4 SMARCA2 EP300	5.49e-05	65	89	5	M39682
Pathway	REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN	CSNK2A1 SMARCA2 AUTS2 EP300	8.36e-05	37	89	4	M27797
Pathway	REACTOME_SIGNALING_BY_NOTCH	MAMLD1 DTX4 DTX2 EP300	1.03e-04	39	89	4	MM14604
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC3A MUC4	1.28e-04	16	89	3	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC3A MUC4	1.55e-04	17	89	3	M27412
Pathway	REACTOME_RORA_ACTIVATES_GENE_EXPRESSION	NCOA2 RXRA EP300	1.85e-04	18	89	3	M26942
Pathway	KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION	RXRA RXRG	3.89e-04	5	89	2	M49023
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC3A MUC4	3.93e-04	23	89	3	M556
Pubmed	A census of human transcription factors: function, expression and evolution.	SOX6 CUX2 ETV1 JDP2 FOXA2 RXRA RXRG HIVEP3 SOX7 TP63 ZNF335 SETBP1 PITX1 NR5A2 HES4 PLAGL2 MAFB DLX5 MBNL3	4.51e-10	908	122	19	19274049
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	NCOA2 TCF20 NSD1 POGZ BCL9 TP63 SMARCA2 EP300	5.75e-10	83	122	8	28794006
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	NCOA2 MYCBP2 BCAS3 KAT6A ETV1 SYNPO ZMIZ1 RXRA HP1BP3 HIVEP3 MRTFB ATXN2 MYH14 SUPT6H KIAA1217 SETBP1 SMARCA2 AUTS2 KATNIP GNAS MAP2K3 EP300 ZMYM4	1.99e-09	1489	122	23	28611215
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	NCOA2 TCF20 MAMLD1 ZMIZ1 BCL9 ANKHD1 FOXA2 NUP35 ATXN2 SMARCA2 AUTS2 DTX2 EP300	8.81e-09	457	122	13	32344865
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RAPGEF6 TCF20 MYCBP2 POGZ BCL9 QSOX1 NOL4L SF3B1 ANAPC1 CSNK2A1 ZNF335 NFRKB SMARCA2 SRRM2 PRG4 ZMYM4	1.43e-08	774	122	16	15302935
Pubmed	Human transcription factor protein interaction networks.	SOX6 NCOA2 TCF20 POGZ ZMIZ1 BCL9 ANKHD1 INO80D RXRA HP1BP3 NOL4L ATXN2 MYH14 CSNK2A1 PITX1 NFRKB SMARCA2 AUTS2 SRRM2 EP300 ZMYM4	2.60e-08	1429	122	21	35140242
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	RAPGEF6 TCF20 MYCBP2 POGZ ZMIZ1 RB1CC1 ANKHD1 NOL4L MRTFB ANAPC1 PPM1F ZMYM4	3.07e-08	418	122	12	34709266
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP28 SYNPO POGZ ANKHD1 ANKLE2 SUPT6H PPM1F SETBP1 NAV2 AUTS2 PLAGL2 RIMS2 ZMYM4	4.90e-08	529	122	13	14621295
Pubmed	Interaction network of human early embryonic transcription factors.	NCOA2 TCF20 POGZ ZMIZ1 BCL9 PITX1 NFRKB SMARCA2 AUTS2 EP300 ZMYM4	4.90e-08	351	122	11	38297188
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	MYCBP2 STIL RB1CC1 SF3B1 ATXN2 SUPT6H CSNK2A1 HES4 RIMS2 SRRM2 EP300	5.98e-08	358	122	11	32460013
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	NCOA2 TCF20 MYCBP2 JDP2 POGZ BCL9 INO80D NOL4L ATXN2 CSNK2A1 PITX1 NFRKB SMARCA2 PLAGL2 ZBTB3 SRRM2 EP300 ZMYM4	6.14e-08	1103	122	18	34189442
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	NCOA2 RAPGEF6 TCF20 MYCBP2 NSD1 POGZ ANKHD1 MRTFB ANAPC1 NFRKB CIZ1 EP300 ZMYM4	7.52e-08	549	122	13	38280479
Pubmed	Prediction of the coding sequences of unidentified human genes. XV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	ZMIZ1 TMCC3 KIAA1210 MRTFB KIAA1217 ITSN2 OGDHL	8.24e-08	103	122	7	10574462
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	SOX6 NCOA2 CUX2 SALL3 TCF20 ETV1 POGZ RXRA HIVEP3 SOX7 NR5A2 CIZ1 SMARCA2 PLAGL2 MBNL3	1.68e-07	808	122	15	20412781
Pubmed	Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.	RXRA NR5A2 SMARCA2 EP300	1.91e-07	15	122	4	14701856
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RAPGEF6 MYCBP2 BCAS3 KAT6A NSD1 BCL9 ANKHD1 HIVEP3 ZNF335 CSPG4 PITX1 NAV2 C19orf44 OGDHL DTX2 BCL2L13 EP300	3.39e-07	1105	122	17	35748872
Pubmed	MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function.	NCOA2 KAT6A RXRA	4.19e-07	5	122	3	15657427
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	SOX6 NCOA2 TCF20 JDP2 RXRA RXRG TP63 NR5A2 HES4 PLAGL2 MAFB DLX5 ZBTB3 EP300 DNMT3A	4.73e-07	877	122	15	20211142
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TCF20 MYCBP2 NSD1 POGZ ANKHD1 HP1BP3 SF3B1 MYH14 ANAPC1 SUPT6H CSNK2A1 SMARCA2 SRRM2	5.41e-07	653	122	13	22586326
Pubmed	Proteomic analysis of steady-state nuclear hormone receptor coactivator complexes.	NCOA2 MYCBP2 SF3B1 CSNK2A1 SRRM2 EP300	5.74e-07	85	122	6	16051665
Pubmed	MOZ is essential for maintenance of hematopoietic stem cells.	MPL KAT6A EP300	8.36e-07	6	122	3	16702405
Pubmed	Transcription factors expressed in olfactory bulb local progenitor cells revealed by genome-wide transcriptome profiling.	ANKHD1 SMARCA2 PLAGL2 MAFB DLX5 DNMT3A	8.60e-07	91	122	6	21194568
Pubmed	The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.	NCOA2 ZMIZ1 BCL9 CIZ1 AUTS2 DTX2 EP300	1.17e-06	152	122	7	38360978
Pubmed	Retinoic acid signalling induces the differentiation of mouse fetal liver-derived hepatic progenitor cells.	NCOA2 FOXA2 RXRA RXRG	1.21e-06	23	122	4	19737349
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	NCOA2 CUX2 TCF20 ETV1 POGZ RXRA RXRG SOX7 NR5A2 SMARCA2 PLAGL2 DLX5 ZBTB3	1.35e-06	709	122	13	22988430
Pubmed	An additional region of coactivator GRIP1 required for interaction with the hormone-binding domains of a subset of nuclear receptors.	NCOA2 RXRA EP300	1.46e-06	7	122	3	9920895
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	NCOA2 CACNA1E CACNB1 TCF20 MYCBP2 USP28 NSD1 SYNPO BCL9 GRM5 SF3B1 ATXN2 ANAPC1 CSNK2A1 KIAA1217	1.51e-06	963	122	15	28671696
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	TCF20 KAT6A NSD1 SYNPO POGZ HP1BP3 CSNK2A1 PITX1 NFRKB CIZ1 ZMYM4 DNMT3A	1.66e-06	608	122	12	36089195
Pubmed	Single cell enhancer activity distinguishes GABAergic and cholinergic lineages in embryonic mouse basal ganglia.	SOX6 CUX2 ETV1 MAFB DLX5	1.77e-06	57	122	5	35377797
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	NCOA2 CACNA1E TCF20 BCAS3 ANKHD1 SF3B1 SCN9A SRRM2	1.80e-06	233	122	8	37704626
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	NCOA2 BCAS3 USP28 JDP2 POGZ ANKHD1 FOXA2 RXRA SF3B1 ANAPC1 DLX5 MAP2K3 EP300 ZMYM4	2.00e-06	857	122	14	25609649
Pubmed	Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu.	NCOA2 ETV1 EP300	2.33e-06	8	122	3	14747462
Pubmed	Multiprotein bridging factor-1 (MBF-1) is a cofactor for nuclear receptors that regulate lipid metabolism.	RXRA NR5A2 EP300	2.33e-06	8	122	3	12040021
Pubmed	The activation function-1 domain of Nur77/NR4A1 mediates trans-activation, cell specificity, and coactivator recruitment.	NCOA2 RXRG EP300	2.33e-06	8	122	3	12082103
Pubmed	Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.	NRG1 RXRG MAFB DLX5	2.76e-06	28	122	4	20392955
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1E CACNB1 SYN3 MYCBP2 BCAS3 SYNPO FMN2 RIMS2 SRRM2	4.01e-06	347	122	9	17114649
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	FBXW10B MUC16 ZMIZ1 TMCC3 SF3B1 CSNK2A1 ZNF335 NAV2 GNAS MUC3A NEK11	4.19e-06	552	122	11	10737800
Pubmed	Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons.	SOX6 CUX2 MAFB DLX5	4.21e-06	31	122	4	23312518
Pubmed	Dynamics of Cux2 expression suggests that an early pool of SVZ precursors is fated to become upper cortical layer neurons.	CUX2 ETV1 DLX5	4.96e-06	10	122	3	15238450
Pubmed	Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.	CUX2 SALL3 ETV1 RXRG MAFB DLX5	6.88e-06	130	122	6	19386638
Pubmed	Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.	CUX2 SALL3 ETV1 RXRG MAFB DLX5	8.19e-06	134	122	6	19030180
Pubmed	Cellular patterns of transcription factor expression in developing cortical interneurons.	CUX2 MAFB DLX5	9.05e-06	12	122	3	16766712
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RAPGEF6 TCF20 MYCBP2 RIMKLA BCAS3 STIL TMCC3 KIAA1217 NAV2 FMN2 GNAS SRRM2 PRRC1	1.10e-05	861	122	13	36931259
Pubmed	Six novel susceptibility Loci for early-onset androgenetic alopecia and their unexpected association with common diseases.	FOXA2 SETBP1 AUTS2	1.17e-05	13	122	3	22693459
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	NCOA2 TCF20 POGZ SOX7 NFRKB CIZ1 SMARCA2 AUTS2 EP300	1.20e-05	398	122	9	35016035
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	CACNA1E CUX2 SYNPO ANKLE2 NUP35 HP1BP3 SF3B1 MYH14 CSPG4 SCN4A ITSN2 SCN9A NAV2 TMEM184C OGDHL RIMS2 CAVIN2	1.20e-05	1442	122	17	35575683
Pubmed	State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.	SCN4A SCN9A	1.22e-05	2	122	2	18079277
Pubmed	Expression of the MOZ-TIF2 oncoprotein in mice represses senescence.	NCOA2 KAT6A	1.22e-05	2	122	2	26854485
Pubmed	Engagement of the mannose receptor by tumoral mucins activates an immune suppressive phenotype in human tumor-associated macrophages.	MRC1 MUC16	1.22e-05	2	122	2	21331365
Pubmed	Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor-Nuclear Receptor Related 1 Protein Dimer Activation.	NCOA2 RXRA	1.22e-05	2	122	2	26820900
Pubmed	Maintaining protein stability of ∆Np63 via USP28 is required by squamous cancer cells.	USP28 TP63	1.22e-05	2	122	2	32128997
Pubmed	Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner.	MYH14 MYBPC3	1.22e-05	2	122	2	34051236
Pubmed	Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.	NCOA2 RXRA	1.22e-05	2	122	2	17947383
Pubmed	Comparison of SF3B1/DNMT3A Comutations With DNMT3A or SF3B1 Mutation Alone in Myelodysplastic Syndrome and Clonal Cytopenia of Undetermined Significance.	SF3B1 DNMT3A	1.22e-05	2	122	2	32112088
Pubmed	Negative impact on clinical outcome of the mutational co-occurrence of SF3B1 and DNMT3A in refractory anemia with ring sideroblasts (RARS).	SF3B1 DNMT3A	1.22e-05	2	122	2	27771989
Pubmed	Medial prefrontal cortical PPM1F alters depression-related behaviors by modifying p300 activity via the AMPK signaling pathway.	PPM1F EP300	1.22e-05	2	122	2	37309288
Pubmed	Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis with Cooccurrent SF3B1 and MPL Gene Mutations: A Case Report and Brief Review of the Literature.	MPL SF3B1	1.22e-05	2	122	2	31858134
Pubmed	SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution.	SF3B1 DNMT3A	1.22e-05	2	122	2	24723457
Pubmed	Foxa2-dependent hepatic gene regulatory networks depend on physiological state.	NCOA2 FOXA2	1.22e-05	2	122	2	19417011
Pubmed	A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia.	NCOA2 KAT6A	1.22e-05	2	122	2	9558366
Pubmed	MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).	KAT6A EP300	1.22e-05	2	122	2	10824998
Pubmed	Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology.	MUC16 MUC4	1.22e-05	2	122	2	23544943
Pubmed	Association of NRG1 and AUTS2 genetic polymorphisms with Hirschsprung disease in a South Chinese population.	NRG1 AUTS2	1.22e-05	2	122	2	29377512
Pubmed	Association between functional genetic variants in retinoid X receptor-α/γ and the risk of gestational diabetes mellitus in a southern Chinese population.	RXRA RXRG	1.22e-05	2	122	2	34633445
Pubmed	The transcription factor PlagL2 activates Mpl transcription and signaling in hematopoietic progenitor and leukemia cells.	MPL PLAGL2	1.22e-05	2	122	2	21263445
Pubmed	The retinoid X receptors and their ligands.	RXRA RXRG	1.22e-05	2	122	2	22020178
Pubmed	Thyroid hormone resistance and increased metabolic rate in the RXR-gamma-deficient mouse.	RXRA RXRG	1.22e-05	2	122	2	10880050
Pubmed	P300 increases CSNK2A1 expression which accelerates colorectal cancer progression through activation of the PI3K-AKT-mTOR axis.	CSNK2A1 EP300	1.22e-05	2	122	2	37391010
Pubmed	Organization of a cytoskeletal superstructure in the apical domain of intestinal tuft cells.	CDHR5 MYH14	1.22e-05	2	122	2	39352498
Pubmed	Structure, energetics, and dynamics of binding coactivator peptide to the human retinoid X receptor α ligand binding domain complex with 9-cis-retinoic acid.	NCOA2 RXRA	1.22e-05	2	122	2	21049972
Pubmed	Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.	NCOA2 RXRA	1.22e-05	2	122	2	24187139
Pubmed	DNA binding by cut homeodomain proteins is down-modulated by casein kinase II.	CUX2 CSNK2A1	1.22e-05	2	122	2	9446557
Pubmed	Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.	TP63 DLX5	1.22e-05	2	122	2	34370013
Pubmed	DNMT3A R882 mutation is associated with elevated expression of MAFB and M4/M5 immunophenotype of acute myeloid leukemia blasts.	MAFB DNMT3A	1.22e-05	2	122	2	25721756
Pubmed	NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma.	NRG1 TP63	1.22e-05	2	122	2	31144617
Pubmed	Retinoid X receptor γ up-regulation is correlated with dedifferentiation of tumor cells and lymph node metastasis in papillary thyroid carcinoma.	RXRA RXRG	1.22e-05	2	122	2	21355951
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	CACNB1 SYNPO HP1BP3 QSOX1 SF3B1 KIAA1217 SETBP1 OSMR SRRM2 ZMYM4	1.41e-05	513	122	10	25798074
Pubmed	Transcription factor protein interactomes reveal genetic determinants in heart disease.	SALL3 NUP35 SF3B1 CSNK2A1 SMARCA2 SRRM2 EP300 ZMYM4 DNMT3A	1.55e-05	411	122	9	35182466
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	KAT6A CSNK2A1 SMARCA2 AUTS2 EP300 DNMT3A	2.02e-05	157	122	6	30186101
Pubmed	Impact of cytosine methylation on DNA binding specificities of human transcription factors.	CUX2 ETV1 JDP2 FOXA2 RXRA RXRG SOX7 PITX1 NR5A2 DLX5	2.33e-05	544	122	10	28473536
Pubmed	Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.	TCF20 MYCBP2 NSD1 ANKHD1 ANAPC1 GNAS MAP2K3	2.46e-05	242	122	7	34011540
Pubmed	NRF1 association with AUTS2-Polycomb mediates specific gene activation in the brain.	CSNK2A1 AUTS2 EP300	2.76e-05	17	122	3	34637754
Pubmed	Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.	NCOA2 SMARCA2 EP300	2.76e-05	17	122	3	19183483
Pubmed	Adipocyte arrestin domain-containing 3 protein (Arrdc3) regulates uncoupling protein 1 (Ucp1) expression in white adipose independently of canonical changes in β-adrenergic receptor signaling.	RXRA RXRG EP300	2.76e-05	17	122	3	28291835
Pubmed	SLFN11 promotes CDT1 degradation by CUL4 in response to replicative DNA damage, while its absence leads to synthetic lethality with ATR/CHK1 inhibitors.	NSD1 NUP35 SF3B1 MYH14 SMARCA2 SRRM2 DNMT3A	3.03e-05	250	122	7	33536335
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	SOX6 NRG1 CUX2 ETV1 RXRA RXRG DLX5	3.10e-05	251	122	7	29031500
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	SALL3 TCF20 POGZ SMARCA2 ZMYM4	3.25e-05	103	122	5	32744500
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC3A MUC4	3.31e-05	18	122	3	18834073
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC4	3.65e-05	3	122	2	23053434
Pubmed	Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.	SF3B1 SETBP1	3.65e-05	3	122	2	25553291
Pubmed	Molecular recognition of agonist ligands by RXRs.	NCOA2 RXRA	3.65e-05	3	122	2	11981034
Pubmed	The "Phantom Effect" of the Rexinoid LG100754: structural and functional insights.	NCOA2 RXRA	3.65e-05	3	122	2	21152046
Pubmed	Integrative analysis of the cancer genome atlas and cancer cell lines encyclopedia large-scale genomic databases: MUC4/MUC16/MUC20 signature is associated with poor survival in human carcinomas.	MUC16 MUC4	3.65e-05	3	122	2	30236127
Pubmed	The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function.	NECAB2 GRM5	3.65e-05	3	122	2	19694902
Pubmed	Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway.	TP63 DLX5	3.65e-05	3	122	2	22342398
Pubmed	The nuclear receptor fetoprotein transcription factor is coexpressed with its target gene HNF-3beta in the developing murine liver, intestine and pancreas.	FOXA2 NR5A2	3.65e-05	3	122	2	10559496
Pubmed	Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects.	RXRA RXRG	3.65e-05	3	122	2	11053444
Pubmed	Retinoid X receptors: X-ploring their (patho)physiological functions.	RXRA RXRG	3.65e-05	3	122	2	15608692
Pubmed	IκB kinase β (IKKβ) inhibits p63 isoform γ (TAp63γ) transcriptional activity.	TP63 EP300	3.65e-05	3	122	2	23589370
Pubmed	Point mutation in the gene encoding p300 suppresses thrombocytopenia in Mpl-/- mice.	MPL EP300	3.65e-05	3	122	2	18684867
Interaction	TLX1 interactions	NCOA2 TCF20 KAT6A POGZ BCL9 HP1BP3 CSNK2A1 SMARCA2 AUTS2 EP300 ZMYM4	7.90e-09	175	120	11	int:TLX1
Interaction	NCOA2 interactions	SOX6 NCOA2 ETV1 SLA RXRA NUP35 SOX7 NR5A2 DLX5 EP300	1.23e-08	141	120	10	int:NCOA2
Interaction	NUP35 interactions	NCOA2 TCF20 MAMLD1 ZMIZ1 BCL9 ANKHD1 FOXA2 NUP35 HIVEP3 ATXN2 SMARCA2 AUTS2 DTX2 EP300	2.37e-07	424	120	14	int:NUP35
Interaction	TBR1 interactions	NCOA2 MYCBP2 ZMIZ1 BCL9 PITX1 SMARCA2 EP300 ZMYM4	3.79e-07	113	120	8	int:TBR1
Interaction	TLE3 interactions	SOX6 NCOA2 TCF20 ZMIZ1 BCL9 INO80D NUP35 SOX7 NR5A2 NFRKB AUTS2 SRRM2 EP300	3.91e-07	376	120	13	int:TLE3
Interaction	KDM1A interactions	SOX6 NECAB2 RAPGEF6 TCF20 MYCBP2 USP28 POGZ ZMIZ1 RB1CC1 ANKHD1 NOL4L MRTFB ANAPC1 PPM1F CSNK2A1 KIAA1217 ITSN2 SMARCA2 EP300 ZMYM4	6.96e-07	941	120	20	int:KDM1A
Interaction	NCOA3 interactions	SOX6 NCOA2 ETV1 RXRA NUP35 SOX7 MRTFB NR5A2 DTX2 EP300	9.41e-07	224	120	10	int:NCOA3
Interaction	HNF1B interactions	SOX6 NCOA2 POGZ BCL9 NUP35 NFRKB SMARCA2 EP300 ZMYM4	2.07e-06	190	120	9	int:HNF1B
Interaction	CRX interactions	NCOA2 TCF20 POGZ ZMIZ1 BCL9 M1AP NFRKB SMARCA2 EP300 ZMYM4	2.92e-06	254	120	10	int:CRX
Interaction	ETV4 interactions	NCOA2 ZMIZ1 BCL9 TP63 SMARCA2 EP300	3.47e-06	69	120	6	int:ETV4
Interaction	TBXT interactions	NCOA2 TCF20 POGZ BCL9 SMARCA2 EP300 ZMYM4	6.07e-06	116	120	7	int:TBXT
Interaction	MDC1 interactions	TCF20 USP28 NSD1 POGZ ATXN2 MYH14 ANAPC1 SUPT6H CSNK2A1 DTX2 EP300 CAVIN2	6.88e-06	414	120	12	int:MDC1
Interaction	USP7 interactions	SOX6 MRC1 NECAB2 SALL3 TCF20 USP28 MRGPRF ETV1 NSD1 JDP2 STIL NUTM1 SF3B1 CSNK2A1 ZNF335 NAV2 MAFB DTX2 SRRM2 MAP2K3 EP300 DNMT3A	9.00e-06	1313	120	22	int:USP7
Interaction	NR1I2 interactions	NCOA2 RXRA RXRG NR5A2 EP300	9.60e-06	48	120	5	int:NR1I2
Interaction	THRB interactions	NCOA2 NSD1 PMEL RXRA RXRG CSPG4 OSMR EP300	1.58e-05	186	120	8	int:THRB
Interaction	FMR1 interactions	NCOA2 CACNB1 NECAB2 TCF20 MYCBP2 USP28 KAT6A BCL9 ATXN2 ANAPC1 CSNK2A1 KIAA1217 ZBTB3	1.88e-05	536	120	13	int:FMR1
Interaction	NCOA6 interactions	NCOA2 RXRA RXRG NUP35 ZNF335 MAFB EP300	2.61e-05	145	120	7	int:NCOA6
Interaction	NANOG interactions	SALL3 TCF20 MUC16 POGZ ZMIZ1 RB1CC1 SUPT6H CSNK2A1 KIAA1217 SMARCA2 EP300 DNMT3A	3.05e-05	481	120	12	int:NANOG
Interaction	NFIC interactions	SOX6 POGZ NUP35 SF3B1 SMARCA2 DTX2 MAP2K3 ZMYM4	3.77e-05	210	120	8	int:NFIC
Interaction	NR1H4 interactions	RXRA RXRG NR5A2 EP300	3.78e-05	32	120	4	int:NR1H4
Interaction	WWTR1 interactions	NCOA2 RAPGEF6 TCF20 MYCBP2 POGZ ANKHD1 NUP35 ANAPC1 TP63 DTX2 EP300	4.47e-05	422	120	11	int:WWTR1
Interaction	SPI1 interactions	KAT6A ETV1 CSNK2A1 EP300 DNMT3A	4.95e-05	67	120	5	int:SPI1
Interaction	THRA interactions	NCOA2 NSD1 RXRA RXRG ZBTB3 EP300	5.35e-05	111	120	6	int:THRA
Interaction	ERG interactions	SOX6 NCOA2 TCF20 ETV1 BCL9 SF3B1 SMARCA2 EP300	5.76e-05	223	120	8	int:ERG
Interaction	NRIP1 interactions	NCOA2 RXRA RXRG SF3B1 CSNK2A1 NR5A2 DNMT3A	7.18e-05	170	120	7	int:NRIP1
Interaction	EGR2 interactions	NCOA2 POGZ BCL9 NFRKB SMARCA2 EP300 ZMYM4	7.45e-05	171	120	7	int:EGR2
Interaction	MAML1 interactions	SOX6 ZMIZ1 NUP35 SOX7 EP300	7.48e-05	73	120	5	int:MAML1
Interaction	SP7 interactions	NCOA2 TCF20 POGZ ZMIZ1 BCL9 PITX1 SMARCA2 DLX5 EP300	8.69e-05	304	120	9	int:SP7
Interaction	AUTS2 interactions	NUP35 CSNK2A1 AUTS2 EP300	9.26e-05	40	120	4	int:AUTS2
Interaction	PIN1 interactions	STIL NUP35 SUPT6H CSNK2A1 TP63 PITX1 PLAGL2 SRRM2 EP300 PRRC1	9.93e-05	383	120	10	int:PIN1
Interaction	VDR interactions	NCOA2 NSD1 RXRA RXRG CSNK2A1 EP300	1.13e-04	127	120	6	int:VDR
Interaction	TERF2IP interactions	NCOA2 TCF20 USP28 NSD1 POGZ HP1BP3 SUPT6H NFRKB CIZ1 SRRM2 ZMYM4 DNMT3A	1.14e-04	552	120	12	int:TERF2IP
Interaction	PAX9 interactions	NCOA2 TCF20 BCL9 SMARCA2 PLAGL2 EP300	1.29e-04	130	120	6	int:PAX9
Interaction	SOX7 interactions	NCOA2 TCF20 SOX7 SMARCA2 EP300	1.30e-04	82	120	5	int:SOX7
Interaction	NFIA interactions	SOX6 NCOA2 BCL9 HP1BP3 SMARCA2 DTX2 EP300	1.35e-04	188	120	7	int:NFIA
Interaction	CEBPA interactions	NCOA2 TCF20 MYCBP2 JDP2 POGZ BCL9 INO80D HP1BP3 NOL4L ATXN2 CSNK2A1 PITX1 NFRKB SMARCA2 PLAGL2 ZBTB3 SRRM2 EP300 ZMYM4	1.38e-04	1245	120	19	int:CEBPA
Interaction	KAT2B interactions	BCAS3 ETV1 JDP2 CSNK2A1 TP63 SMARCA2 MAFB EP300	1.50e-04	256	120	8	int:KAT2B
Interaction	RARB interactions	RXRA RXRG EP300 DNMT3A	1.61e-04	46	120	4	int:RARB
Interaction	KLF5 interactions	NCOA2 BCL9 RXRA TP63 SMARCA2 EP300 ZMYM4	1.69e-04	195	120	7	int:KLF5
Interaction	H3C3 interactions	TCF20 NSD1 POGZ HP1BP3 SUPT6H CSNK2A1 PITX1 NFRKB CIZ1 ZMYM4 DNMT3A	1.83e-04	495	120	11	int:H3C3
Interaction	HMGA1 interactions	SOX6 TCF20 KAT6A NSD1 POGZ RXRA HP1BP3 CSNK2A1 MAFB ZMYM4	2.06e-04	419	120	10	int:HMGA1
Interaction	NFIB interactions	SOX6 BCL9 NUP35 SOX7 SMARCA2 DTX2	2.08e-04	142	120	6	int:NFIB
Interaction	PHF21A interactions	RAPGEF6 MYCBP2 ZMIZ1 RB1CC1 ANKHD1 SOX7 MRTFB ANAPC1 PPM1F	2.15e-04	343	120	9	int:PHF21A
Interaction	FEV interactions	NCOA2 TCF20 POGZ BCL9 NFRKB EP300 ZMYM4	2.16e-04	203	120	7	int:FEV
Interaction	SOX10 interactions	NCOA2 BCL9 SMARCA2 DLX5 EP300	2.24e-04	92	120	5	int:SOX10
Interaction	NCOA1 interactions	NCOA2 FOXA2 RXRA SOX7 NR5A2 EP300	2.42e-04	146	120	6	int:NCOA1
Interaction	CREBBP interactions	NCOA2 KAT6A JDP2 RB1CC1 RXRA RXRG NUP35 SOX7 SUPT6H CSNK2A1 SMARCA2 EP300	2.42e-04	599	120	12	int:CREBBP
Interaction	NHLRC4 interactions	POGZ PITX1 DTX2	2.53e-04	21	120	3	int:NHLRC4
Interaction	SOX17 interactions	NCOA2 TCF20 BCL9 SMARCA2 DNMT3A	2.60e-04	95	120	5	int:SOX17
Interaction	AR interactions	NCOA2 TCF20 MYCBP2 USP28 NSD1 ZMIZ1 BCL9 SF3B1 MYH14 CSNK2A1 KIAA1217 NFRKB SMARCA2 GNAS EP300 ZMYM4	2.66e-04	992	120	16	int:AR
Interaction	RIC8A interactions	NECAB2 NUTM1 TP63 GNAS EP300	2.73e-04	96	120	5	int:RIC8A
Interaction	LHX8 interactions	BCL9 NUTM1 CSNK2A1 SMARCA2	2.79e-04	53	120	4	int:LHX8
Interaction	BAG2 interactions	NCOA2 RAPGEF6 TCF20 STIL ANKHD1 MRTFB SUPT6H NFRKB CIZ1 SRRM2 EP300 MBNL3	3.41e-04	622	120	12	int:BAG2
Interaction	MAMLD1 interactions	MAMLD1 NUP35	3.48e-04	5	120	2	int:MAMLD1
Interaction	KLF15 interactions	NCOA2 POGZ BCL9 HP1BP3 NOL4L NFRKB EP300 ZMYM4	3.49e-04	290	120	8	int:KLF15
Interaction	NUCKS1 interactions	TCF20 KAT6A POGZ HP1BP3 CSNK2A1 EP300 ZMYM4	3.52e-04	220	120	7	int:NUCKS1
Interaction	FBRS interactions	SOX6 NUP35 SOX7 CSNK2A1 AUTS2	3.62e-04	102	120	5	int:FBRS
Interaction	NR6A1 interactions	NSD1 EP300 DNMT3A	3.80e-04	24	120	3	int:NR6A1
Interaction	NFIX interactions	SOX6 POGZ NFRKB SMARCA2 DTX2 ZMYM4 MYBPC3	4.25e-04	227	120	7	int:NFIX
Interaction	GOLGA2 interactions	NCOA2 NECAB2 TCF20 LCP2 ANKHD1 MYH14 KIAA1217 ITSN2 PITX1 C19orf44 DTX2 MAP2K3 EP300	4.29e-04	733	120	13	int:GOLGA2
Interaction	ALX1 interactions	MPL NUP35 EP300	4.30e-04	25	120	3	int:ALX1
Interaction	SETSIP interactions	KAT6A CSNK2A1 EP300	4.30e-04	25	120	3	int:SETSIP
Interaction	LHX4 interactions	NCOA2 POGZ BCL9 NFRKB SMARCA2 ZMYM4	4.81e-04	166	120	6	int:LHX4
Interaction	HOXB7 interactions	ANKHD1 CSNK2A1 EP300	4.84e-04	26	120	3	int:HOXB7
Interaction	SIRT7 interactions	TCF20 MYCBP2 NSD1 POGZ ANKHD1 HP1BP3 SF3B1 MYH14 ANAPC1 SUPT6H CSNK2A1 SMARCA2 SRRM2	4.93e-04	744	120	13	int:SIRT7
Interaction	JUN interactions	NCOA2 TCF20 BCAS3 ETV1 NSD1 JDP2 CSNK2A1 SMARCA2 MAFB EP300	5.10e-04	470	120	10	int:JUN
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	NCOA2 KAT6A EP300	5.22e-05	17	79	3	486
GeneFamily	CD molecules\|Mucins	MUC16 MUC3A MUC4	1.01e-04	21	79	3	648
GeneFamily	Sodium voltage-gated channel alpha subunits	SCN4A SCN9A	6.65e-04	9	79	2	1203
GeneFamily	Nuclear hormone receptors	RXRA RXRG NR5A2	1.28e-03	49	79	3	71
GeneFamily	INO80 complex \|SRCAP complex	INO80D NFRKB	1.91e-03	15	79	2	595
GeneFamily	SRY-boxes	SOX6 SOX7	3.07e-03	19	79	2	757
GeneFamily	PWWP domain containing	NSD1 DNMT3A	4.11e-03	22	79	2	1147
GeneFamily	Calcium voltage-gated channel subunits	CACNA1E CACNB1	5.72e-03	26	79	2	253
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NCOA2 NRG1 MYCBP2 KAT6A MAMLD1 ZMIZ1 STIL RB1CC1 ANKLE2 SEC24D ATXN2 CSNK2A1 ITSN2 SMARCA2 OSMR ZMYM4	2.37e-06	856	122	16	M4500
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	UBL7 SOX6 NRG1 TCF20 POGZ ZMIZ1 RXRG TMCC3 HP1BP3 MYH14 KIAA1217 SETBP1 ITSN2 SMARCA2 NAV2 AUTS2 GNAS	4.49e-06	1009	122	17	M157
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000	MPL NRG1 CUX2 NECAB2 MAMLD1 SYNPO ZMIZ1 LCP2 HIVEP3 MYH14 TP63 CSPG4 PITX1 SCN9A NAV2 FMN2 DLX5 RIMS2 MUC4	2.62e-06	984	120	19	Facebase_RNAseq_e10.5_Olfactory Pit_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000	CUX2 MAMLD1 SYNPO ZMIZ1 LCP2 HIVEP3 QSOX1 MRTFB MYH14 TP63 CSPG4 PITX1 NR5A2 FMN2 MAFB DLX5 MBNL3	3.10e-05	967	120	17	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000	MRC1 CACNB1 CUX2 MAMLD1 SYNPO ZMIZ1 BCL9 LCP2 HIVEP3 MYH14 TP63 SETBP1 CSPG4 SMARCA2 FMN2 MAFB MUC4	3.35e-05	973	120	17	Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000	NRG1 CUX2 NECAB2 SALL3 MAMLD1 SYNPO ZMIZ1 LCP2 HIVEP3 QSOX1 MYH14 TP63 DTX4 CSPG4 FMN2 DLX5 RIMS2	3.48e-05	976	120	17	Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000	MPL CUX2 MAMLD1 SYNPO ZMIZ1 STIL BCL9 LCP2 HIVEP3 QSOX1 MYH14 TP63 CSPG4 PITX1 FMN2 DLX5 MUC4	3.57e-05	978	120	17	Facebase_RNAseq_e10.5_Mandibular Arch_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	NCOA2 CUX2 MYCBP2 RIMKLA BCAS3 ETV1 ZMIZ1 BCL9 FOXA2 NOL4L ANAPC1 TP63 PITX1 FMN2 ZMYM4	5.89e-05	818	120	15	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#5	MPL MRC1 ETV1 SYNPO ZMIZ1 BCL9 LCP2 MYH14 RTL9 NR5A2 KATNIP MAFB MUC4 DNMT3A	6.97e-05	734	120	14	Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K5
CoexpressionAtlas	FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500	CUX2 MAMLD1 SYNPO ZMIZ1 LCP2 HIVEP3 MYH14 TP63 CSPG4 FMN2 DLX5	1.05e-04	489	120	11	Facebase_RNAseq_e8.5_Paraxial Mesoderm_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	MINAR2 CUX2 SALL3 ETV1 SYNPO ZMIZ1 BCL9 TP63 PITX1 AUTS2 FMN2 DLX5 OSMR RIMS2	1.14e-04	769	120	14	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000	CUX2 NECAB2 MAMLD1 SYNPO ZMIZ1 HIVEP3 MRTFB MYH14 TP63 KIAA1217 CSPG4 PITX1 NAV2 FMN2 DLX5 MBNL3	1.18e-04	973	120	16	Facebase_RNAseq_e9.5_Olfactory Placode_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	SOX6 CUX2 MAMLD1 ZMIZ1 HIVEP3 DTX4 SETBP1 SCN9A FMN2 DLX5 RIMS2	1.19e-04	496	120	11	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#4	SOX6 MAMLD1 DTX4 SETBP1 FMN2 RIMS2	1.40e-04	139	120	6	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	MRC1 CUX2 ETV1 ZMIZ1 HIVEP3 SF3B1 ATXN2 CSNK2A1 KIAA1217 SMARCA2 NAV2 DLX5 MBNL3 DNMT3A	1.74e-04	801	120	14	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5	MPL SYNPO ZMIZ1 LCP2 HIVEP3 MYH14 CSPG4 MUC4	1.76e-04	276	120	8	Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL TMCC3 KIAA1217 SCN9A MAFB MYO16	1.06e-06	193	122	7	4979862c0c16e6b4baa4c79894f1d237c861f5a5
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 NSD1 RFX6 NAV2 FMN2 SRRM2 DNMT3A	1.13e-06	195	122	7	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 MRC1 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.34e-06	200	122	7	858421b91f5207b7934b5c219752cb9322a3da31
ToppCell	Bronchial_Brush-Epithelial-Basal_2\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	NRG1 HP1BP3 SOX7 TP63 HES4 MAFB CAVIN2	1.34e-06	200	122	7	1fa29a9f42987549a75dffeb177099458f7cca88
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Bronchial_Brush-Epithelial-Basal_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	NRG1 HP1BP3 SOX7 TP63 HES4 MAFB CAVIN2	1.34e-06	200	122	7	7595eb2a8af3de879ecaa71f3d96f890e13b59ce
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 MRC1 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.34e-06	200	122	7	a7022762c1d8aedb7b3e9605873b1e68b9907b35
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-B3GAT2--L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 MRC1 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.34e-06	200	122	7	2131c8e7fa054b79906eaf60536da892438b09cd
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	SOX6 GRM5 KIAA1217 CSPG4 SCN9A RIMS2 MYO16	1.34e-06	200	122	7	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Globus_pallidus-Neuronal-Excitatory\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CACNA1E CACNB1 SYNPO RXRG MRTFB MUC3A	5.29e-06	160	122	6	f843287ed57d2d5a3b3f6dfb03b6934e330e6645
ToppCell	Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	CACNA1E CACNB1 SYNPO RXRG MRTFB MUC3A	5.49e-06	161	122	6	ebcd5066e82b7760b9da6adc02d11258d1309dab
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1E NRG1 RFX6 VWDE FMN2 RIMS2	6.77e-06	167	122	6	c87ebfa8c3284ad33579190e148c95bcaf670d17
ToppCell	Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	CACNA1E NRG1 RFX6 VWDE FMN2 RIMS2	7.25e-06	169	122	6	b6b5bb6408c1305a00719e1b88a5e1202081faf3
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MINAR2 MRGPRF SYNPO TMCC3 FMN2 MAFB	8.01e-06	172	122	6	381ae1c3c07d0a424f43455ec571653b192a946a
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MINAR2 MRGPRF SYNPO TMCC3 FMN2 MAFB	8.56e-06	174	122	6	dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 SALL3 TP63 KIAA1217 PITX1 MUC4	9.43e-06	177	122	6	cbad1a23851151dbef01ea2af960e6f0944f838b
ToppCell	nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NRG1 SALL3 TP63 KIAA1217 PITX1 MUC4	9.43e-06	177	122	6	ce86dfaeb74d995a19aea62f0fb15c4c0bb854b0
ToppCell	5'-Adult-LymphNode-Endothelial-blood_vessel_EC-arterial_capillary\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ETV1 MUC16 SOX7 KIAA1217 SCN4A CAVIN2	9.74e-06	178	122	6	360d7a987f91d6d721487a921824057ec31a7332
ToppCell	Epithelial-lung_neuroendocrine_cell_(PNEC)\|World / Lineage, Cell type, age group and donor	NRG1 SYN3 RFX6 VWDE FMN2 RIMS2	1.11e-05	182	122	6	57bf4ffb304324e2e392e196336a530d9f78fe0d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMCC3 KIAA1217 SCN9A MAFB MYO16	1.14e-05	183	122	6	d2074b13b4831ec18c81273d9a1ff673c3f6a16d
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KAT6A NSD1 HP1BP3 ITSN2 EP300	1.18e-05	184	122	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	droplet-Marrow-nan-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 KAT6A NSD1 ANKLE2 ITSN2 EP300	1.21e-05	185	122	6	7adfa929930cfa795cbfbd9f1a0b439e08aa765d
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 CUX2 KIAA1217 SCN9A MAFB MYO16	1.21e-05	185	122	6	e87e6e097dc29ece8aea671935bde281b99b93ea
ToppCell	Mild_COVID-19-Epithelial-AT1/AT2\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	RIMKLA ETV1 SOX7 SCN9A NAV2 OGDHL	1.21e-05	185	122	6	c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB MYO16	1.21e-05	185	122	6	f4ac62009c0ad3346e71b809e17727303c4df153
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL SCN9A MAFB DLX5 MYO16	1.25e-05	186	122	6	948815663c212c4311329d503b5991cbbbff9808
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRG1 SYN3 RFX6 VWDE FMN2 RIMS2	1.25e-05	186	122	6	b45cce768e4bf91da194fd9660cab7520dfb15ac
ToppCell	Control-Endothelial-Endothelial-Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KAT6A MRTFB KIAA1217 SCN9A SMARCA2 CAVIN2	1.29e-05	187	122	6	ea9d34bcd3bd1f36745846309ede349773de501a
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANKLE2 QSOX1 NAV2 OSMR MUC4 MYO16	1.33e-05	188	122	6	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRG1 SYN3 RFX6 VWDE FMN2 RIMS2	1.33e-05	188	122	6	c4c3b21ab723b0e9beff9ec84f8d68485f771528
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB MYO16	1.33e-05	188	122	6	8de5a07301f9b5984680c873e5a92395b5ed3dd3
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.37e-05	189	122	6	06c44746fa4f02e6e2b3b635cdf2d8dfef3754d3
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL SCN9A MAFB DLX5 MYO16	1.37e-05	189	122	6	78cf414b98bcb19deb934409acddaad1cd51b67f
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB DLX5	1.41e-05	190	122	6	26843ec1d19ac85a50990705353b802745d33e4d
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYCBP2 KAT6A ETV1 TMCC3 SMARCA2 CAVIN2	1.41e-05	190	122	6	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB MYO16	1.41e-05	190	122	6	305fbef734c350cfbf786ca7ff6e07093aab56ea
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB MYO16	1.41e-05	190	122	6	0acf1d5da68db449d8c9e70519a236ce825f9d11
ToppCell	LAM-Epithelial-AT1\|Epithelial / Condition, Lineage and Cell class	NRG1 RIMKLA SYNPO NAV2 HES4 CAVIN2	1.45e-05	191	122	6	3457e15d1e9b36a78363d46b320c4ec46b40290a
ToppCell	Control-Endothelial-VE_Capillary_B\|Control / Disease state, Lineage and Cell class	SYN3 SOX7 KIAA1217 NR5A2 OSMR CAVIN2	1.45e-05	191	122	6	322237793a1278bafb14e63cab688b353e352dcc
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.45e-05	191	122	6	9c0ee270209b02043393416ecc9a81ddedfbb8b6
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-4_LAMP5_DUSP4_(Lamp5_Rosehip)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NECAB2 ETV1 MYRFL LCP2 HES4 MYO16	1.50e-05	192	122	6	342842378c20267c5044bdd622515e8b9f895623
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 NECAB2 MYRFL LCP2 MAFB DLX5	1.50e-05	192	122	6	67d6230e32d446dcb12047fae2c3f1faa80dd720
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	NRG1 CUX2 SYN3 JDP2 SCN9A MYO16	1.50e-05	192	122	6	25460ca9ebd3d49f666394cf99ab77a5e8f77250
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.54e-05	193	122	6	2c15186d15545804cc262da9137ab825609d4b2c
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYN3 SOX7 MRTFB NR5A2 OSMR CAVIN2	1.54e-05	193	122	6	9ba688b35a9ead5d04691b3f3f15484f02dbbd0d
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.54e-05	193	122	6	8b77625bf3c87d39767fb391d1beaca4ab02342b
ToppCell	IPF-Endothelial-VE_Venous\|IPF / Disease state, Lineage and Cell class	SYN3 SOX7 MRTFB NR5A2 OSMR CAVIN2	1.54e-05	193	122	6	29a655fa80feaabe846c90a28363b037e22d24ae
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 MYRFL KIAA1217 SCN9A MAFB MYO16	1.54e-05	193	122	6	c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9
ToppCell	IPF-Endothelial-VE_Venous\|World / Disease state, Lineage and Cell class	SYN3 SOX7 MRTFB NR5A2 OSMR CAVIN2	1.54e-05	193	122	6	ef66a46e7ab44fcc4005a23416e6da478a4cce37
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NECAB2 MUC16 RFX6 PMEL FMN2 OGDHL	1.59e-05	194	122	6	2dcc3b99dbedaf8a6916891c85091ddb79d7ee31
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	SOX6 NECAB2 MYRFL MAFB DLX5 MYO16	1.59e-05	194	122	6	4f758718a1233c25c25d99fc1b7b06f906b8b0a2
ToppCell	severe_COVID-19-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	MRC1 JDP2 PPM1F HES4 PLAGL2 MAFB	1.63e-05	195	122	6	72928a1d987a3a5361c666f3972292aefec5f548
ToppCell	mild_COVID-19_(asymptomatic)-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	RXRA HIVEP3 PPM1F HES4 PLAGL2 MAFB	1.63e-05	195	122	6	eb809331557f8c40de45b1208cbc49b621930a4b
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 KIAA1217 PITX1 DTX2 RIMS2 MUC4	1.63e-05	195	122	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 RFX6 NAV2 FMN2 SRRM2 DNMT3A	1.63e-05	195	122	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	severe_COVID-19-Non-classical_Monocyte\|severe_COVID-19 / disease group, cell group and cell class (v2)	MRC1 JDP2 RXRA PPM1F HES4 PLAGL2	1.68e-05	196	122	6	34c1c74cad5e23196e86cfd6f19c836fe57b2264
ToppCell	droplet-Tongue-TONGUE-1m-Epithelial\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 RXRA GRID2IP CSNK2A1 PITX1 SRRM2	1.68e-05	196	122	6	a85f5f1e6acc798e9e02b1a21e0ffe87a323c333
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MYH14 PITX1 HES4 DTX2 MUC4	1.68e-05	196	122	6	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MYH14 PITX1 HES4 DTX2 MUC4	1.68e-05	196	122	6	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MYH14 PITX1 HES4 DTX2 MUC4	1.68e-05	196	122	6	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	Control_saline-Epithelial_alveolar-AT_2-Differentiating_AT2\|Control_saline / Treatment groups by lineage, cell group, cell type	SOX6 ETV1 FOXA2 MYH14 NAV2 OGDHL	1.73e-05	197	122	6	44a59dfb889577b3160a5b13ada1276771a00241
ToppCell	normal_Lung-Myeloid_cells-Monocytes\|normal_Lung / Location, Cell class and cell subclass	NRG1 LCP2 RXRA PPM1F HES4 MAFB	1.73e-05	197	122	6	f32f1a0455c2cfdd5f187b10f6a3fd4877874c09
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRGPRF MUC16 KIAA1217 CSPG4 MUC3A CAVIN2	1.78e-05	198	122	6	5cfd1c030c0940136a397b5a4b5d6ecbaecf72eb
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRGPRF MUC16 KIAA1217 CSPG4 MUC3A CAVIN2	1.78e-05	198	122	6	ff6d9455ebfe965cc6f48197172c0ebd3bddde81
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	GRM5 MRTFB SETBP1 FMN2 GNAS RIMS2	1.78e-05	198	122	6	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRGPRF MUC16 KIAA1217 CSPG4 MUC3A CAVIN2	1.78e-05	198	122	6	5375a2895cf995f0db4a61861093f01794707901
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Hematopoietic-Megakaryocytic-Megakaryocyte\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MRGPRF MUC16 KIAA1217 CSPG4 MUC3A CAVIN2	1.78e-05	198	122	6	35edf6d5bedc2181fbdd56f43e458bc39f4eca16
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 KIAA1217 DTX4 HES4 DTX2 MUC4	1.78e-05	198	122	6	fab3135f03cf23a9f04f0eed543a9dc181f39f5f
ToppCell	Healthy_donor-Non-classical_Monocyte\|Healthy_donor / disease group, cell group and cell class (v2)	JDP2 RXRA PPM1F HES4 PLAGL2 MAFB	1.78e-05	198	122	6	d4eae333fa100db3ea2d4cbe7a1d6ab14816f0e2
ToppCell	Healthy/Control-Non-classical_Monocyte\|Healthy/Control / Disease group and Cell class	JDP2 RXRA PPM1F HES4 PLAGL2 MAFB	1.78e-05	198	122	6	0badaf1fa5328d06291c3624d0f63196ffc81527
ToppCell	3'_v3-Lung-Myeloid_Monocytic\|Lung / Manually curated celltypes from each tissue	JDP2 RXRA PPM1F HES4 MAFB MAP2K3	1.83e-05	199	122	6	3e14f9a62d6414add8d5f681be184b4625001838
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	JDP2 ZMIZ1 LCP2 RXRA HES4 MAFB	1.83e-05	199	122	6	fa5ad81554969fffe5e779614d071d9194a7182c
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD16\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	LCP2 SLA RXRA NOL4L PPM1F MAFB	1.83e-05	199	122	6	ac866ae110967c5867ff4601939b79861d43df54
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1--L1-3\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 CUX2 KIAA1217 SMARCA2 AUTS2 MAFB	1.89e-05	200	122	6	f3c710f0fc8a7bfb5371d1aff6e3d8f266953153
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 KIAA1217 DTX4 HES4 DTX2 MUC4	1.89e-05	200	122	6	b992eeddee38e6fe3564e9b1850f6b20b89bf47d
ToppCell	Tracheal-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MYH14 TP63 KIAA1217 PITX1 MUC4	1.89e-05	200	122	6	efd461c687155c84ef590352207e6fe4ba392a90
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 CUX2 KIAA1217 SMARCA2 AUTS2 MAFB	1.89e-05	200	122	6	70a06fd7fb8de2c8ec3e3182e4476ced049daeae
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2--L2-4\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 TMCC3 KIAA1217 SCN9A MAFB MYO16	1.89e-05	200	122	6	c65e6336725856c4b5f6aeba1cf86a23ec815d34
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 TMCC3 KIAA1217 NAV2 AUTS2 MAFB	1.89e-05	200	122	6	347a510755374c6a66acee326565dfc447993f18
ToppCell	Neuronal-Inhibitory-iB-iB_4(SST)-CALB1\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 CUX2 KIAA1217 SMARCA2 AUTS2 MAFB	1.89e-05	200	122	6	1639982d9d994918f7912d12d9d7cfcbc9da4145
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	MUC16 MYH14 TP63 KIAA1217 PITX1 MUC4	1.89e-05	200	122	6	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 TMCC3 KIAA1217 SCN9A MAFB MYO16	1.89e-05	200	122	6	117a25b3b9cdbc2e198381350a8362bee25e82e7
ToppCell	Neuronal-Inhibitory-iB-iB_2(PVALB)-WFDC2\|Neuronal / cells hierarchy compared to all cells using T-Statistic	SOX6 TMCC3 KIAA1217 SCN9A MAFB MYO16	1.89e-05	200	122	6	d459e51507bf26865e6e7e04411379ec82a3edf8
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 RFX6 TMCC3 MAFB DLX5	2.17e-05	122	122	5	eae9d94f8510ac0f434942451d55c7260977b178
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MINAR2 DNAAF8 HIVEP3 NFRKB SCN9A	3.79e-05	137	122	5	dd5364a1002650d21e0c83d8c701b5f7b09d1c19
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	NRG1 CUX2 GRM5 FMN2 RIMS2	4.06e-05	139	122	5	a1945b07f177cde40e7eea03a19236ce76165857
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	NECAB2 RXRA SCN9A DLX5 GNAS	4.06e-05	139	122	5	408bc31aa5e1c2b379f79198fe8b5411f8d7bd08
ToppCell	3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3\|bone_marrow / Manually curated celltypes from each tissue	TNFRSF25 MYRFL SCN9A NAV2 OSMR	5.65e-05	149	122	5	d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MINAR2 STIL LCP2 TP63 MAFB	6.41e-05	153	122	5	8cc2667213bfac37545bb63181e88ef1f1834413
ToppCell	facs-Lung-18m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MINAR2 STIL LCP2 TP63 MAFB	6.41e-05	153	122	5	596bb7cfd1c713708ce73df30d890a0233eae7f7
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SOX6 NRG1 TMCC3 MAFB DLX5	6.82e-05	155	122	5	5c7b68b59244525e3714806c205a57a2daebf423
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SOX7 PPM1F NR5A2 CAVIN2 MBNL3	7.03e-05	156	122	5	1928c86deb3bcd01db4ae76919a351066aadb39a
ToppCell	Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRG1 SYN3 RFX6 FMN2 RIMS2	7.69e-05	159	122	5	7747cef94c55144fddcd024a7495318357f1351b
ToppCell	LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	NRG1 LCP2 HIVEP3 MAFB ZBTB3	7.92e-05	160	122	5	5d8d97c3da5837ba5fe743d2f8438f5cb7cea64b
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 KIAA1217 HES4 DTX2 MUC4	8.16e-05	161	122	5	2d63b279d9a5132e1c09b03930bf9039036d24a2
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-enterocyte_of_epithelium_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TRPM6 CDHR5 TMCC3 MYH14 MAFB	8.40e-05	162	122	5	bc63a96ad3ba0b3433e3679d7a005f47709ff384
Drug	Timolol maleate salt [26921-17-5]; Up 200; 9.2uM; PC3; HT_HG-U133A	TNFRSF25 ETV1 HP1BP3 MYH14 TP63 PITX1 NFRKB MUC4 MYBPC3	1.06e-06	196	121	9	4685_UP
Drug	AC1L9K70	NCOA2 TNFRSF25 JDP2 RXRA RXRG TP63 NR5A2 DLX5 EP300	3.70e-06	228	121	9	CID000446871
Drug	6-mercaptopurine monohydrate; Down 200; 10uM; PC3; HG-U133A	FOXA2 RXRA HIVEP3 ATXN2 SUPT6H ZNF335 PITX1 SMARCA2	9.88e-06	195	121	8	667_DN
Drug	genistein; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 SUPT6H PPM1F PITX1 SMARCA2 SRRM2 ZMYM4 NEK11	1.03e-05	196	121	8	6994_DN
Drug	(R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; MCF7; HT_HG-U133A	NECAB2 INO80D PITX1 NFRKB GNAS OSMR RIMS2 DNMT3A	1.10e-05	198	121	8	6096_DN
Drug	Meropenem [96036-03-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A	ANKLE2 QSOX1 SEC24D MYH14 ZNF335 PITX1 MAFB MAP2K3	1.10e-05	198	121	8	7180_DN
Drug	Ceftazidime pentahydrate [78439-06-2]; Up 200; 6.2uM; MCF7; HT_HG-U133A	CACNB1 TNFRSF25 SLA HP1BP3 SEC24D SUPT6H NAV2 OSMR	1.10e-05	198	121	8	5473_UP
Drug	Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A	NCOA2 POGZ SEC24D ZNF335 CIZ1 TMEM184C PLAGL2 SRRM2	1.19e-05	200	121	8	5853_DN
Drug	saxitoxin	PMEL SCN4A SCN9A DTX2 MYBPC3	2.50e-05	65	121	5	CID000037165
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	NCOA2 NSD1 ZMIZ1 RXRA PITX1 SRRM2 EP300	3.28e-05	168	121	7	3868_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	NCOA2 TNFRSF25 SYNPO FOXA2 CSNK2A1 ZNF335 SRRM2	3.81e-05	172	121	7	6439_DN
Drug	AC1L2E0P	NCOA2 KAT6A NSD1 JDP2 RXRA RXRG NR5A2 SMARCA2 EP300	3.95e-05	307	121	9	CID000019390
Drug	scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ZMIZ1 RXRA HP1BP3 CSNK2A1 ZNF335 PITX1	4.91e-05	179	121	7	6901_DN
Drug	Bexarotene	RXRA RXRG	8.37e-05	3	121	2	DB00307
Drug	2-hydroxyphytanic acid	RXRA RXRG	8.37e-05	3	121	2	ctd:C002585
Drug	AC1O5SBP	RXRA RXRG	8.37e-05	3	121	2	CID006439746
Drug	N-(2-methyl-3-(4-(4-(4-(trifluoromethoxy)benzyloxy)piperidin-1-yl)-1,3,5-triazin-2-ylamino)phenyl)acetamide	SCN4A SCN9A	8.37e-05	3	121	2	ctd:C561228
Drug	Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	KAT6A SYNPO BCL9 PPM1F PITX1 SRRM2 MAP2K3	8.41e-05	195	121	7	6338_DN
Drug	Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A	BCL9 INO80D HIVEP3 NAV2 OSMR RIMS2 DNMT3A	8.41e-05	195	121	7	3478_UP
Drug	Flurandrenolide [1524-88-5]; Up 200; 9.2uM; MCF7; HT_HG-U133A	TNFRSF25 NECAB2 SYN3 MYH14 SCN4A MUC4 DNMT3A	8.41e-05	195	121	7	6039_UP
Drug	Hydrastinine hydrochloride [4884-68-8]; Down 200; 16.4uM; MCF7; HT_HG-U133A	TNFRSF25 POGZ INO80D HIVEP3 PITX1 NFRKB RIMS2	8.41e-05	195	121	7	2283_DN
Drug	Butylparaben [94-26-8]; Up 200; 20.6uM; PC3; HT_HG-U133A	TRPM6 CDHR5 SLA MYH14 TP63 DLX5 MUC4	8.41e-05	195	121	7	4647_UP
Drug	Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; MCF7; HT_HG-U133A	INO80D RXRA HIVEP3 SEC24D PITX1 NFRKB OSMR	8.41e-05	195	121	7	2264_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	BCAS3 ATXN2 ZNF335 CIZ1 SMARCA2 GNAS SRRM2	8.69e-05	196	121	7	2056_DN
Drug	Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A	TRPM6 CACNB1 SYN3 SLA HIVEP3 TP63 MYBPC3	8.69e-05	196	121	7	4406_UP
Drug	Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A	POGZ BCL9 SUPT6H ZNF335 KATNIP GNAS SRRM2	8.69e-05	196	121	7	7124_DN
Drug	Proguanil hydrochloride [637-32-1]; Up 200; 13.8uM; MCF7; HT_HG-U133A	ETV1 PMEL SLA INO80D TP63 RIMS2 NEK11	8.97e-05	197	121	7	5506_UP
Drug	radicicol; Up 200; 0.1uM; PC3; HG-U133A	SYNPO POGZ PMEL CIZ1 SMARCA2 SRRM2 MYBPC3	8.97e-05	197	121	7	484_UP
Drug	Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	CACNB1 SYN3 INO80D SEC24D TP63 AUTS2 MUC4	9.26e-05	198	121	7	3326_UP
Drug	Dihydroergotoxine mesylate [8067-24-1]; Up 200; 6.4uM; PC3; HT_HG-U133A	CACNB1 TNFRSF25 SYN3 SLA TP63 RIMS2 SRRM2	9.26e-05	198	121	7	4071_UP
Drug	Azathioprine [446-86-6]; Up 200; 14.4uM; PC3; HT_HG-U133A	TNFRSF25 SYN3 ETV1 SEC24D SUPT6H SRRM2 DNMT3A	9.26e-05	198	121	7	4667_UP
Drug	Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A	NCOA2 MAMLD1 SYNPO HP1BP3 SUPT6H DTX4 SRRM2	9.26e-05	198	121	7	6287_DN
Drug	Streptomycin sulfate [3810-74-0]; Up 200; 2.8uM; PC3; HT_HG-U133A	BCAS3 INO80D SEC24D ITSN2 SCN9A OSMR NEK11	9.26e-05	198	121	7	5837_UP
Drug	Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HT_HG-U133A	TNFRSF25 KAT6A ETV1 NSD1 SEC24D PITX1 SRRM2	9.26e-05	198	121	7	4023_DN
Drug	Moroxidine hydrochloride [3160-91-6]; Up 200; 19.2uM; MCF7; HT_HG-U133A	NCOA2 TNFRSF25 KAT6A PMEL SEC24D CSNK2A1 SRRM2	9.55e-05	199	121	7	1527_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	NCOA2 KAT6A POGZ PITX1 NAV2 AUTS2 SRRM2	9.55e-05	199	121	7	2319_DN
Drug	Minoxidil [38304-91-5]; Down 200; 19.2uM; PC3; HG-U133A	NSD1 POGZ RB1CC1 MYH14 CIZ1 GNAS EP300	9.85e-05	200	121	7	1914_DN
Drug	valdecoxib; Up 200; 10uM; MCF7; HT_HG-U133A	NCOA2 ETV1 DNAAF8 MYH14 OGDHL GNAS MUC4	9.85e-05	200	121	7	6403_UP
Drug	Chlorthalidone [77-36-1]; Up 200; 11.8uM; PC3; HT_HG-U133A	BCAS3 ETV1 SYNPO HIVEP3 SEC24D SMARCA2 GNAS	9.85e-05	200	121	7	7152_UP
Drug	alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A	MPL MYH14 TP63 SCN4A GNAS MUC4 MYBPC3	9.85e-05	200	121	7	5570_UP
Drug	retinol palmitate	RXRA RXRG EP300	1.13e-04	18	121	3	ctd:C014794
Drug	androst-2-en-3-ol	NCOA2 RXRA RXRG	1.13e-04	18	121	3	CID000166036
Disease	Intellectual Disability	CACNA1E CUX2 TCF20 NSD1 POGZ ZMIZ1 SLC5A6 ZNF335 SETBP1 GNAS DNMT3A	2.25e-06	447	120	11	C3714756
Disease	anthropometric measurement	SYN3 MYCBP2 ZMIZ1 ATXN2 MAFB DLX5 DNMT3A	5.93e-06	168	120	7	EFO_0004302
Disease	waist-hip ratio	CUX2 MYCBP2 NSD1 ZC3H11B C11orf24 ZMIZ1 LCP2 ATXN2 CSNK2A1 SETBP1 SCN4A NR5A2 MAFB MAP2K3 ZMYM4 DNMT3A	3.82e-05	1226	120	16	EFO_0004343
Disease	cystatin C measurement	CUX2 BCAS3 NSD1 FOXA2 ATXN2 KIAA1217 CSPG4 GNAS MYBPC3	4.08e-05	402	120	9	EFO_0004617
Disease	Craniofacial Abnormalities	SALL3 TP63 SETBP1 DLX5 EP300 DNMT3A	4.41e-05	156	120	6	C0376634
Disease	Prostatic Neoplasms	NCOA2 USP28 KAT6A ETV1 RFX6 RXRA SF3B1 MYH14 ITSN2 CIZ1 MUC4	4.47e-05	616	120	11	C0033578
Disease	Malignant neoplasm of prostate	NCOA2 USP28 KAT6A ETV1 RFX6 RXRA SF3B1 MYH14 ITSN2 CIZ1 MUC4	4.47e-05	616	120	11	C0376358
Disease	Ischemic stroke	NCOA2 NRG1 USP28 VWDE ATXN2 SETBP1 AUTS2 TMEM184C	5.61e-05	324	120	8	HP_0002140
Disease	Adenoid Cystic Carcinoma	KAT6A NSD1 DTX4 SMARCA2 EP300	5.66e-05	100	120	5	C0010606
Disease	blood phosphate measurement	CUX2 SYN3 BCAS3 NSD1 ATXN2 MAFB	8.08e-05	174	120	6	EFO_0010972
Disease	FEV/FEC ratio	SYN3 BCAS3 ETV1 NSD1 ZC3H11B RFX6 MYRFL HIVEP3 NOL4L ANAPC1 CSPG4 NAV2 MAFB PRG4 MYO16	1.41e-04	1228	120	15	EFO_0004713
Disease	Colorectal Carcinoma	CACNB1 SALL3 ETV1 ZMIZ1 HIVEP3 PPM1F TP63 SETBP1 GNAS EP300 ZMYM4	1.42e-04	702	120	11	C0009402
Disease	alcohol consumption measurement	NCOA2 CACNA1E CUX2 SYN3 USP28 ZC3H11B RFX6 GRM5 INO80D SETBP1 AUTS2 HES4 RIMS2 EP300 MYBPC3	1.60e-04	1242	120	15	EFO_0007878
Disease	Myopia	BCAS3 ZC3H11B ANKLE2 NUP35 HIVEP3 NR5A2 KATNIP GNAS	1.84e-04	385	120	8	HP_0000545
Disease	mean arterial pressure	SOX6 CUX2 TCF20 RXRA HIVEP3 ATXN2 KIAA1217 AUTS2 GNAS	2.10e-04	499	120	9	EFO_0006340
Disease	hair colour measurement	SOX6 NRG1 CUX2 ETV1 ZMIZ1 GRM5 TP63 SETBP1 FMN2 MAFB	2.14e-04	615	120	10	EFO_0007822
Disease	Global developmental delay	CACNA1E TCF20 ZMIZ1 SLC5A6 ZNF335	2.17e-04	133	120	5	C0557874
Disease	intraocular pressure measurement	SYN3 BCAS3 ETV1 RXRA HIVEP3 ATXN2 ANAPC1 CSPG4 MYBPC3	2.43e-04	509	120	9	EFO_0004695
Disease	diastolic blood pressure, unipolar depression	SOX6 CUX2 ATXN2	2.46e-04	30	120	3	EFO_0003761, EFO_0006336
Disease	Schizophrenia	NRG1 RAPGEF6 SYN3 RB1CC1 BCL9 GRM5 ATXN2 SMARCA2 AUTS2 GNAS RIMS2 MYO16	2.62e-04	883	120	12	C0036341
Disease	microcephaly (implicated_via_orthology)	STIL ANKLE2 AUTS2	2.98e-04	32	120	3	DOID:10907 (implicated_via_orthology)
Disease	Ectrodactyly	TP63 DLX5	3.40e-04	7	120	2	C0265554
Disease	biological sex	SOX6 ATXN2 SETBP1 SMARCA2 AUTS2 RIMS2	3.66e-04	230	120	6	PATO_0000047
Disease	acute myeloid leukemia (is_implicated_in)	NCOA2 KAT6A NSD1 DNMT3A	3.91e-04	84	120	4	DOID:9119 (is_implicated_in)
Disease	Ewings sarcoma	ETV1 CIZ1	4.52e-04	8	120	2	C0553580
Disease	Developmental delay (disorder)	TCF20 SLC5A6 ZNF335	4.61e-04	37	120	3	C0424605
Disease	physical activity measurement	SOX6 GRM5 HP1BP3 SMARCA2 AUTS2 RIMS2	5.12e-04	245	120	6	EFO_0008002
Disease	generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology)	SCN4A SCN9A	7.23e-04	10	120	2	DOID:0111294 (implicated_via_orthology)
Disease	Dravet syndrome (implicated_via_orthology)	SCN4A SCN9A	7.23e-04	10	120	2	DOID:0080422 (implicated_via_orthology)
Disease	Leukemia, Myelocytic, Acute	NSD1 SF3B1 SETBP1 EP300 DNMT3A	7.24e-04	173	120	5	C0023467
Disease	adipose tissue measurement	NRG1 TP63 MYO16	8.22e-04	45	120	3	EFO_0004764
Disease	alkaline phosphatase measurement	SOX6 NCOA2 CUX2 ZMIZ1 VWDE HP1BP3 HIVEP3 ATXN2 FMN2 MAFB DLX5 MYBPC3	8.99e-04	1015	120	12	EFO_0004533
Disease	glucose measurement	CUX2 MYCBP2 RFX6 FOXA2 ATXN2 AUTS2 MYBPC3	9.52e-04	380	120	7	EFO_0004468
Disease	neutrophil-to-lymphocyte ratio	CUX2 JDP2 ATXN2 C19orf44 DNMT3A	9.77e-04	185	120	5	EFO_0008447
Disease	Malignant mesothelioma	RXRA SF3B1 SMARCA2 OSMR	1.04e-03	109	120	4	C0345967
Disease	generalized epilepsy with febrile seizures plus (implicated_via_orthology)	SCN4A SCN9A	1.05e-03	12	120	2	DOID:0060170 (implicated_via_orthology)
Disease	Dental enamel hypoplasia	ZMIZ1 MYH14	1.05e-03	12	120	2	EFO_1001304
Disease	urate measurement	NRG1 CUX2 BCAS3 NSD1 C11orf24 ZMIZ1 ATXN2 SETBP1 CSPG4 FMN2 GNAS	1.08e-03	895	120	11	EFO_0004531
Disease	obsolete_red blood cell distribution width	SOX6 TNFRSF25 SYN3 BCAS3 HP1BP3 SOX7 NOL4L KIAA1217 NFRKB SMARCA2 MAFB MUC4 EP300 MYO16	1.17e-03	1347	120	14	EFO_0005192
Disease	sitting height ratio	NSD1 ZMIZ1 ITSN2	1.18e-03	51	120	3	EFO_0007118
Disease	Orofacial cleft	NRG1 TP63 MAFB	1.18e-03	51	120	3	HP_0000202
Disease	alcohol use disorder (implicated_via_orthology)	CIZ1 SMARCA2 AUTS2 SRRM2 EP300	1.23e-03	195	120	5	DOID:1574 (implicated_via_orthology)
Disease	body surface area	SYN3 NSD1 ZC3H11B ZMIZ1 SCN4A ITSN2 AUTS2 GNAS DNMT3A	1.28e-03	643	120	9	EFO_0022196
Disease	monoclonal gammopathy	SETBP1 AUTS2 RIMS2	1.32e-03	53	120	3	EFO_0000203
Disease	response to 5-fluorouracil, response to cyclophosphamide, chemotherapy-induced alopecia, response to doxorubicin	BCL9 SMARCA2	1.45e-03	14	120	2	EFO_0005400, GO_0036275, GO_1902518, GO_1902520
Disease	electrocardiography	NCOA2 NRG1 MYCBP2 ZMIZ1 RXRG SETBP1 NAV2 MYBPC3	1.49e-03	530	120	8	EFO_0004327
Disease	Aganglionosis, Colonic	NRG1 CAVIN2	1.66e-03	15	120	2	C0085758
Disease	Autosomal recessive primary microcephaly	STIL ZNF335	1.66e-03	15	120	2	cv:C3711387
Disease	Aganglionosis, Rectosigmoid Colon	NRG1 CAVIN2	1.66e-03	15	120	2	C1257840
Disease	diastolic blood pressure, systolic blood pressure	SOX6 MRC1 NRG1 ZC3H11B BCL9 TMCC3 QSOX1 ATXN2 SETBP1	1.70e-03	670	120	9	EFO_0006335, EFO_0006336
Disease	hair color	SOX6 TCF20 ETV1 ZMIZ1 GRM5 FMN2	1.75e-03	311	120	6	EFO_0003924
Disease	sexual dimorphism measurement	MINAR2 RAPGEF6 SYN3 MRGPRF NSD1 ZC3H11B ZMIZ1 ZNF335 SCN4A PITX1 DNMT3A MYBPC3	1.86e-03	1106	120	12	EFO_0021796
Disease	Neuralgia, Supraorbital	GRM5 SCN9A	1.90e-03	16	120	2	C0038870
Disease	Neuralgia	GRM5 SCN9A	1.90e-03	16	120	2	C0027796
Disease	Neuralgia, Atypical	GRM5 SCN9A	1.90e-03	16	120	2	C0234247
Disease	Neuralgia, Stump	GRM5 SCN9A	1.90e-03	16	120	2	C0234249
Disease	Neuralgia, Iliohypogastric Nerve	GRM5 SCN9A	1.90e-03	16	120	2	C0423712
Disease	Neuralgia, Perineal	GRM5 SCN9A	1.90e-03	16	120	2	C0423711
Disease	Paroxysmal Nerve Pain	GRM5 SCN9A	1.90e-03	16	120	2	C0751373
Disease	Nerve Pain	GRM5 SCN9A	1.90e-03	16	120	2	C0751372
Disease	Neuralgia, Ilioinguinal	GRM5 SCN9A	1.90e-03	16	120	2	C0751371
Disease	Neuralgia, Vidian	GRM5 SCN9A	1.90e-03	16	120	2	C0042656
Disease	cortical thickness	NCOA2 MYCBP2 SLA NOL4L SF3B1 ATXN2 NAV2 AUTS2 FMN2 DLX5 OSMR MYO16	1.96e-03	1113	120	12	EFO_0004840
Disease	response to opioid	MUC16 GRM5 TP63	1.99e-03	61	120	3	EFO_0008541
Disease	pancreatic ductal carcinoma (is_marker_for)	RXRA MUC3A MUC4	1.99e-03	61	120	3	DOID:3587 (is_marker_for)
Disease	Seizures	CACNA1E CUX2 ZMIZ1 CSNK2A1 SLC5A6	2.01e-03	218	120	5	C0036572
Disease	thyroid stimulating hormone measurement	NRG1 BCAS3 SLA ATXN2 KIAA1217 GNAS	2.11e-03	323	120	6	EFO_0004748
Disease	Multiple congenital anomalies	TP63 SETBP1	2.14e-03	17	120	2	C0000772
Disease	Congenital Intestinal Aganglionosis	NRG1 CAVIN2	2.14e-03	17	120	2	C3661523
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC3A MUC4	2.28e-03	64	120	3	DOID:4947 (is_marker_for)
Disease	Feeding difficulties	ZMIZ1 SLC5A6	2.40e-03	18	120	2	C0232466
Disease	apolipoprotein A 1 measurement	NCOA2 NSD1 ZC3H11B RFX6 ZMIZ1 GRM5 ATXN2 CSNK2A1 HES4 MYBPC3	2.47e-03	848	120	10	EFO_0004614
Disease	Profound Mental Retardation	NSD1 SETBP1 GNAS DNMT3A	2.54e-03	139	120	4	C0020796
Disease	Mental Retardation, Psychosocial	NSD1 SETBP1 GNAS DNMT3A	2.54e-03	139	120	4	C0025363
Disease	Mental deficiency	NSD1 SETBP1 GNAS DNMT3A	2.54e-03	139	120	4	C0917816
Disease	Microcephaly	ZMIZ1 SLC5A6 DNMT3A	2.60e-03	67	120	3	C0025958
Disease	MYELODYSPLASTIC SYNDROME	MPL SF3B1 SETBP1	2.60e-03	67	120	3	C3463824
Disease	Juvenile Myelomonocytic Leukemia	SETBP1 DNMT3A	2.68e-03	19	120	2	C0349639
Disease	age at onset, smoking initiation	NCOA2 MYCBP2	2.68e-03	19	120	2	EFO_0004847, EFO_0005670
Disease	schizophrenia (implicated_via_orthology)	NRG1 GRM5 RIMS2	2.71e-03	68	120	3	DOID:5419 (implicated_via_orthology)
Disease	hematocrit	SOX6 NRG1 BCAS3 MAMLD1 SYNPO RXRA TMCC3 ATXN2 NR5A2 OSMR DNMT3A	2.82e-03	1011	120	11	EFO_0004348
Disease	eosinophil count	CUX2 RAPGEF6 JDP2 RFX6 LCP2 ANKLE2 SLA HIVEP3 NOL4L ATXN2 ANAPC1 MAFB BCL2L13 MYO16	2.93e-03	1488	120	14	EFO_0004842
Disease	serum albumin measurement	SOX6 MRC1 MAMLD1 ZC3H11B ATXN2 RTL9 MAFB MYBPC3	2.95e-03	592	120	8	EFO_0004535
Disease	multiple sclerosis	NCOA2 TNFRSF25 JDP2 ZMIZ1 SLA ATXN2 DNMT3A MYBPC3	3.02e-03	594	120	8	MONDO_0005301
Disease	red blood cell density measurement	SOX6 NRG1 BCAS3 ZC3H11B ATXN2 PPM1F NR5A2 MUC4 MYO16 DNMT3A	3.21e-03	880	120	10	EFO_0007978
Disease	eosinophil percentage of leukocytes	UBL7 JDP2 RFX6 LCP2 SLA HIVEP3 NOL4L ATXN2 ANAPC1	3.48e-03	746	120	9	EFO_0007991
Disease	autism spectrum disorder (implicated_via_orthology)	TCF20 SYN3 POGZ RIMS2	3.50e-03	152	120	4	DOID:0060041 (implicated_via_orthology)
Disease	uric acid measurement	NRG1 CUX2 SYN3 BCAS3 ZMIZ1 SETBP1 NR5A2 GNAS	3.54e-03	610	120	8	EFO_0004761
Disease	non-small cell lung carcinoma	NCOA2 NRG1 TP63	3.58e-03	75	120	3	EFO_0003060
Disease	renal system measurement, blood urea nitrogen measurement	BCAS3 GNAS	3.59e-03	22	120	2	EFO_0004741, EFO_0004742
Disease	Autosomal Recessive Primary Microcephaly	STIL ANKLE2	3.59e-03	22	120	2	C3711387
Disease	fat intake measurement	ITSN2 DNMT3A	3.59e-03	22	120	2	EFO_0010809
Disease	reticulocyte count	SOX6 BCAS3 ZC3H11B INO80D NOL4L ATXN2 SETBP1 NFRKB OSMR MAP2K3 DNMT3A	3.62e-03	1045	120	11	EFO_0007986
Disease	unipolar depression, bipolar disorder	SOX6 CACNA1E GRM5 SETBP1	3.84e-03	156	120	4	EFO_0003761, MONDO_0004985
Disease	generalized anxiety disorder	SOX6 VWDE	3.92e-03	23	120	2	EFO_1001892
Disease	Drugs used in diabetes use measurement	MYCBP2 NSD1 ZC3H11B ZMIZ1 AUTS2	3.94e-03	255	120	5	EFO_0009924
Disease	osteoarthritis, knee	ZC3H11B KIAA1217 EP300 CAVIN2	4.02e-03	158	120	4	EFO_0004616

Protein segments in the cluster

Peptide	Gene	Start	Entry
QDAISIASSMPPSPM	TMEM184C	381	Q9NVA4
SRLSPAGEMKPMPLS	BCL2L13	441	Q9BXK5
SMMLVPEPTRKFPSG	C2orf16	26	Q68DN1
TMTPAETSPTMGPPD	GNAS	511	P84996
NPMMSENASVPSLGP	EP300	541	Q09472
PPSAAAAPASGEMTM	ANKLE2	51	Q86XL3
MSDGASPPLPMSLAV	CSPG4	1921	Q6UVK1
MVQKTSMSRGPYPPS	CACNB1	1	Q02641
KAKEVSPMSAPNMPS	CACNA1E	731	Q15878
MPAMPSSGPGDTSSS	DNMT3A	1	Q9Y6K1
PGTSQPMPPSMGTST	CDHR5	576	Q9HBB8
ASSPGLMMSVSPVPS	CUX2	1401	O14529
QASSMPTGTTMGSPA	DTX4	261	Q9Y2E6
PKISDDTPLEMMTSP	BCAS3	636	Q9H6U6
MKNGEMPPEHSPSSS	DLX5	196	P56178
TPMASSPRPKMDAIL	HP1BP3	151	Q5SSJ5
TGMAAQAPKMSDKPP	NSD1	2241	Q96L73
VSPKAPSMLGLMTSP	OSMR	876	Q99650
STLDPGKPEMMKSPT	QSOX1	576	O00391
GKPEMMKSPTNTTPH	QSOX1	581	O00391
MTPPISPAMASRGSV	RFX6	641	Q8HWS3
SSASTMGAPPSMLPE	RIMKLA	361	Q8IXN7
SSATSGTNLPPLMMP	ITSN2	141	Q9NZM3
KSPPSEMSPPVSSMT	NRG1	446	Q02297
IPGLPAPSLTMSNTM	ANAPC1	511	Q9H1A4
APSLTMSNTMPRPST	ANAPC1	516	Q9H1A4
MSNTMPRPSTPLDGV	ANAPC1	521	Q9H1A4
VQPMTGGMAPTTAPT	FBXW10B	726	O95170
SSPNPISDPQSPEMM	RB1CC1	746	Q8TDY2
LRTASMDLPSPTPSM	MUC16	1811	Q8WXI7
PSTATSPMVPASSMG	MUC16	4561	Q8WXI7
SSLMSSPAMTSPSPV	MUC16	5336	Q8WXI7
GFSLMSPSMTSPSPV	MUC16	5631	Q8WXI7
SPLKMETPGMTTPSL	MUC4	4256	Q99102
NSMMLSTAAPSPGVG	GRM5	1076	P41594
MAAELSMGPELPTSP	MAFB	1	Q9Y5Q3
MTPVPGRASKMPAAS	M1AP	496	Q8TC57
SQMSLSDSSMPPTPV	NFRKB	706	Q6P4R8
PENPMMSGSTKPEQV	MYO16	381	Q9Y6X6
SSSPGSVPATVPMQM	DTX2	311	Q86UW9
LSAVPTSMGDMPSAP	KATNIP	701	O60303
TSMGDMPSAPATSPP	KATNIP	706	O60303
AHGSPAPVSTMPKRM	ATXN2	601	Q99700
APVSTMPKRMSSEGP	ATXN2	606	Q99700
MMPGQIPDPSVTTGS	JDP2	1	Q8WYK2
MSNKELFPPSPSEMG	ARNTL2	556	Q8WYA1
MAAVTMSVPGRKAPP	MYH14	1	Q7Z406
PKSMTCPATGIPEDM	OGDHL	586	Q9ULD0
TADSPPPSMSSVMKN	MINAR2	76	P59773
PSSVGISGSLPMMTD	MUC3A	1581	Q02505
MVGSAASQSFPPPLM	ETV1	241	P50549
MAPPVSLEPMGSLSA	MRTFB	951	Q9ULH7
SSSVHPGPLASMPMT	AUTS2	1011	Q8WXX7
PPMHPLQSTSGMGDS	MYRFL	96	Q96LU7
TTMAEDMSPGPPIFN	NEK11	546	Q8NG66
NGMEMTRPTPPHLTS	NOL4L	251	Q96MY1
ASALPGPDMSMKPSA	NUTM1	6	Q86Y26
GPDMSMKPSAAPSPS	NUTM1	11	Q86Y26
KMDRPSISVTSPMSP	RIMS2	781	Q9UQ26
FTPAPMIMEIPESGS	KAT6A	1711	Q92794
TPTTIPDGMGANIPM	TP63	491	Q9H3D4
TSLPETPNPKMMSAV	GRID2IP	541	A4D2P6
QDSTSSMQPPSEAPM	C19orf44	446	Q9H6X5
SPDEMVPPSMNSQSG	BCL9	441	O00512
MASNDKGMAPSLGSP	DNAAF8	1	Q8IYS4
MMSGISSVPTPSPLG	CSNK2A1	351	P68400
SHFVSEPGPQKMPSM	MAMLD1	546	Q13495
KMPSMPTTSRQPSLL	MAMLD1	556	Q13495
MAADTPGKPSASPMA	HES4	1	Q9HCC6
MSSLGSFPMTPSIPA	MBNL3	111	Q9NUK0
MGPSAELMASTSPKQ	INO80D	956	Q53TQ3
GPEPERSASKMFPSM	KIAA1210	236	Q9ULL0
SDMRQEKPSSPSPMP	CAVIN2	16	O95810
LPCTESSSSMPGLGM	FMN2	861	Q9NZ56
MASGMDKARTGSSPP	SALL3	1256	Q9BXA9
SVISSPMGPHSMSVP	RXRA	66	P19793
MSSGAPQKSSPMASG	PPM1F	1	P49593
MIQPMASPSNSSTVP	OR56A1	1	Q8NGH5
PALGSEPMMLGSPTS	NUP35	11	Q8NFH5
MESPASSQPASMPQS	MAP2K3	1	P46734
ATTVMPTMPSVPSGC	MRC1	931	P22897
SPMPGSLAMGPVTNK	FOXA2	416	Q9Y261
VTSPISMTMPPHGSL	NR5A2	241	O00482
MGNSMKSTPAPAERP	SLA	1	Q13239
MSTQPVPAPSSEAMS	RTL9	216	Q8NET4
FMRASVSGSMPMPLP	RTL9	1031	Q8NET4
VSGSMPMPLPRATAS	RTL9	1036	Q8NET4
TPLMRASGPGTMSTP	RTL9	1071	Q8NET4
SSMTMPSSMGPGAVP	PITX1	221	P78337
SKMSQLPMPGGTAPS	SYN3	391	O14994
ALGQSPGVSMMSPVP	SOX7	261	Q9BT81
AKSSEMSPVPMRSAG	RAPGEF6	1151	Q8TEU7
FSASPMLKSGMSPEQ	SRRM2	1121	Q9UQ35
AGPTMGLMPISPSDT	SCN4A	1801	P35499
PSVSHPMPTMGSTDF	SMARCA2	51	P51531
MESSKSGMPGVSLTP	TMCC3	181	Q9ULS5
STPNTVTMEMQCPPG	MRGPRF	326	Q96AM1
VKAGQMMTASPSPGP	SYNPO	111	Q8N3V7
VTSMGSSMPPSPSNG	SLC5A6	476	Q9Y289
FSQMTPVRPGSTMPV	POGZ	206	Q7Z3K3
SMPREGSTSKQMPPS	NAV2	2426	Q8IVL1
SRSPPMLPVNGKMHS	SCN9A	606	Q15858
GAPQTSRMPVPMSAK	KIAA1217	1741	Q5T5P2
PESNMKSMPPSLETS	MYCBP2	3446	O75592
MMEESGIETTPPGTP	PRRC1	1	Q96M27
MPTAESTGMTPEKVP	PMEL	366	P40967
TPRKMTSTMPELNPT	PRG4	1051	Q92954
MGMSYPLESSPISSP	PLAGL2	321	Q9UPG8
DPSHTASPTGMMKPA	SEC24D	31	O94855
SMQVSPGAKMPSTPQ	SOX6	376	P35712
AQPSSVSDLSPMSMP	ANKHD1	2081	Q8IWZ3
AMPPATYDTAGLTMP	CIZ1	101	Q9ULV3
PMSTRPSPSKHMPSD	C11orf24	226	Q96F05
NMTPSMVAPSGMPAT	NCOA2	1271	Q15596
MVAPSGMPATMSNPR	NCOA2	1276	Q15596
TGATTPQSPLMSPRM	NCOA2	1316	Q15596
SPSPMIESTPMSIAG	SUPT6H	1701	Q7KZ85
MSDTLPVSMTSPGKP	VWDE	606	Q8N2E2
TPKTESDNGMMGLSP	STIL	706	Q15468
PEPMTMSSPLSQAKI	TRPM6	1431	Q9BX84
GKTPIGTPAMNMATP	SF3B1	356	O75533
SPSSDMRPKPLGTHM	HIVEP3	961	Q5T1R4
LSMMDPSPSKTPITL	VWCE	901	Q96DN2
PMPGTDSSSRSMPSS	UBL7	201	Q96S82
MDSTLEPSAGAPPTM	RAET1G	201	Q6H3X3
SMSPSAALSTGKPMD	RXRG	26	P48443
TMPLSVCPPMAESGS	MPL	601	P40238
TSSRSSMEMPSQPAP	USP28	516	Q96RU2
TPSMMPSPNSHAAGF	TCF20	421	Q9UGU0
LSPESPAGSPAMMLQ	TNFRSF25	316	Q93038
PEVSGPSSSQMSMKT	ZC3H11B	741	A0A1B0GTU1
MSPGMPSPHLKVDQT	SETBP1	1331	Q9Y6X0
PDDGAPMTSPMSSST	ZNF335	171	Q9H4Z2
ASSGMNKMLPSVPAT	ZMYM4	321	Q5VZL5
GKLPMQPPLSSMSSM	ZMIZ1	121	Q9ULJ6
QPPLSSMSSMKPTLS	ZMIZ1	126	Q9ULJ6
EPPMSSGADTTQPGM	ZBTB3	236	Q9H5J0
STKPSPMNPLPSSHM	LCP2	346	Q13094
AIGMSRPSPASQPFM	MYBPC3	851	Q14896
SPTPASAPNHKLMAM	NECAB2	216	Q7Z6G3